Scholars Central

Conference abstract

Comparative study between GeneXpert and smear microscopy for the diagnosis of tuberculosis in samples of patients suspected of pulmonary tuberculosis: The case study of General Hospital, Awo-Omamma Imo State, Nigeria

Authors: Osuoha Chinyere Beatrice

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Tuberculosis (TB) caused by Mycobacterium tuberculosis, has remained a major scourge of humanity all over the world, with the greatest mortality occurrences noted in developing countries. The cannot-be-overemphasized burden of TB in Nigeria is among the highest in Africa. The study on hand was therefore aimed at comparing Cepheid GeneXpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex (MTBC) and Rifampin (RIF) resistance with the traditional smear microscopy method - the ZN technique. Sensitivity and specificity of diagnostic yields were high points of comparison. A carefully designed cross-sectional study was drawn and executed at the General Hospital, Awo-Omamma, covering patientsâ?? inflow from August 2016 to May 2017. Amongst the numerous patients presenting, a total of 120 samples were collected from patients with highest pulmonary concerns, having been assessed prognostically. 62 (74.4%) were males, 58 (25.6%) were females and all having mean ages of 42.2±16 years and about 30 patients (36%) had chronic lung diseases. Out of the 120 samples examined, 36 samples (43.2%) were MTBC positive by smear microscopy while 42 (50.4%) were positive by GeneXpert assay. Only one sample showed false-negative result for GeneXpert. Placing both methods (GeneXpert and Smear microscopy) side-by-side, GeneXpert gave 85% sensitivity and 98.5% specificity. GeneXpert indeed detected 6 (7.2%) additional positive cases as compared to smear microscopy. Only five clinical isolates of the entire patients were resistant to Rifampin. The study therefore concluded that GeneXpert was a better and more reliable diagnostic tool compared to smear microscopy and can significantly reduce false-negatives and very interestingly, rules out the unnecessary delays often experienced hitherto with Smear microscopy in treatment initiation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Microbiology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Microbiology: Open Access
  • SubjectMicrobiology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Osuoha Chinyere Beatrice”